NewsEarningsArunjyothi Bio Ventures Reports Q1 Profit Surge, Announces Leadership Renewals and Auditor ChangeArunjyothi Bio Ventures Reports Q1 Profit Surge, Announces Leadership Renewals and Auditor Change
Arunjyothi Bio Ventures Limited reported a 39.69% increase in net profit to ₹236.39 lakhs for Q1 FY2026, despite a 13.73% decrease in net sales to ₹871.24 lakhs. The company's total expenses reduced by 17.52%, contributing to improved profitability. The board approved reappointments of three whole-time directors for three-year terms. M/s. PKF Sridhar & Santhanam LLP was appointed as the new statutory auditors, replacing M/s. V Ravi & Co.
*this image is generated using AI for illustrative purposes only.
Arunjyothi Bio Ventures Limited, a company involved in retail chain stores, import-export, and trading in beverages and building materials, has reported a significant increase in profit for the first quarter, along with key leadership reappointments and a change in statutory auditors.
Financial Performance
The company's unaudited financial results for Q1 show a robust performance:
| Particulars (₹ in lakhs) | Q1 FY2026 | Q1 FY2025 | Change (%) |
|---|---|---|---|
| Net Sales | 871.24 | 1,009.89 | -13.73% |
| Total Income | 872.45 | 1,019.93 | -14.46% |
| Total Expenses | 655.54 | 794.81 | -17.52% |
| Profit Before Tax | 216.91 | 225.12 | -3.65% |
| Net Profit | 236.39 | 169.23 | +39.69% |
| Earnings Per Share (₹) | 0.13 | 0.11 | +18.18% |
Despite a 13.73% decrease in net sales to ₹871.24 lakhs from ₹1,009.89 lakhs in the same quarter last year, Arunjyothi Bio Ventures managed to significantly boost its bottom line. The company's net profit surged by 39.69% to ₹236.39 lakhs, compared to ₹169.23 lakhs in the corresponding period of the previous year.
The improved profitability can be attributed to a substantial reduction in total expenses, which decreased by 17.52% year-over-year. This cost management strategy helped offset the impact of lower sales, resulting in a higher net profit margin.
Leadership Reappointments
The board of directors approved the reappointment of three whole-time directors for three-year terms, effective November 10, 2025:
- Mr. Badari Narayana Murthy Pabbathi: With 23 years of experience in retail chain stores, import-export, trading, banking, and insurance.
- Mr. Dathvik Pabbathi: Son of Mr. Badari Narayana Murthy Pabbathi, bringing six years of experience in the company's core business areas.
- Mr. Nadimpalli Vishal: A postgraduate in business management with over 12 years of experience in distribution, manufacturing, wholesale trade, and e-commerce.
These reappointments are subject to shareholder approval and aim to ensure continuity in the company's leadership.
Auditor Transition
Arunjyothi Bio Ventures announced a change in its statutory auditors:
- M/s. V Ravi & Co., Chartered Accountants, resigned as the company's statutory auditors due to pre-occupation after completing one five-year term.
- M/s. PKF Sridhar & Santhanam LLP, a leading chartered accountancy firm with over 45 years of experience, has been appointed as the new statutory auditors for a five-year term, effective August 4, 2025, subject to shareholder approval.
Other Key Information
- The company's paid-up equity share capital stands at ₹1,863.81 lakhs.
- Arunjyothi Bio Ventures completed a stock split on January 17, 2025, changing the face value of shares from ₹10 to ₹1 per share.
- The total number of outstanding shares post-split is 18,63,81,000.
The company's ability to increase profitability despite lower sales demonstrates effective cost management and operational efficiency. The leadership renewals and auditor change indicate a focus on maintaining strong governance and financial oversight as Arunjyothi Bio Ventures moves forward in its growth trajectory.
Historical Stock Returns for Arunjyothi Bio Ventures
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -4.92% | +15.40% | +68.09% | -20.48% | -19.03% | +6,993.33% |
20
